Results

Total Results: 77 records

Showing results for "central venous".

61. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - breathlessness, fatigue, ankle swelling), and signs (tachycardia, tachypnea, rales, increased jugular venous … The search will be conducted in four databases: Medline, Embase, Cochrane Central and AMED. … 14 or/1-13 15 limit 14 to yr=1989-Current CCRT Database: EBM Reviews - Cochrane Central

62. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - ES 3 Central Nervous System Disorder Intervention ................................................. … Neurostimulation (remedē System) for treatment of central sleep apnea associated with heart failure …  Key Facts: Multiple sclerosis (MS) is a progressive autoimmune disorder directed against the central …  Potential for High Impact: Moderately high 1 Central Nervous System Disorder Intervention … Chronic cerebrospinal venous insufficiency and the doubtful promise of an endovascular treatment

63. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
    February 16, 2011 - Ablation of endometrial implants o Resection of peritoneum (partial) o Diagnostic laparoscopy (only) o Venous

64. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
    May 01, 2011 - Database of Systematic Reviews; Database of Abstracts of Reviews of Effects; EBM Reviews – Cochrane Central … complications (2 RCTs, n=128; 1 cohort study, n=99); damage to surrounding structures (3 RCTs, n=224); deep venous

65. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
    September 01, 2012 - Sensitivity is a central variable in this context because the primary aim of the title and abstract … were initiated according to the demands of the new trials and former programs were enhanced: (1) central … The central prospective radiation oncological review of all diagnostic imaging (HD10, HD11) showed … The introduction of teleradiotherapy into the GHSG trials improves the dialogue between the central … Technical limitations owing to individual coronary sinus and coronary venous anatomy result in a 10%

66. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - hemangioma and vertebral hemangioma are usually a misnomer due to issues with terminology, and actually venous … 9) ES-22 – may also want to mention that the long-term side effects of propranolol therapy on the central

67. CERs Report cover (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - strategies from the CER were re-searched from January 2009 to July 14, 2010 in MEDLINE, the Cochrane Central … Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy … Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based … Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal … 12 3 and 8 1044 13 12 not 11 320 14 limit 13 to yr="2009 -Current" 23 EBM Reviews—Cochrane Central

68. Future Research Needs Document (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - strategies from the CER were re-searched from January 2009 to July 14, 2010 in MEDLINE, the Cochrane Central … Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy … Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based … Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal … 12 3 and 8 1044 13 12 not 11 320 14 limit 13 to yr="2009 -Current" 23 EBM Reviews—Cochrane Central

69. Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
    September 01, 2015 - Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in

70. Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
    July 08, 2015 - Preoperative fascia iliaca compartment block for positioning patients with hip fractures for central … Deep venous thrombosis (2 RCTs, n=100) •! … Deep venous thrombosis (2 RCTs, n=100) •!

71. Renal-Cancer Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
    February 01, 2016 - tumors are determined to be locally advanced cancers (stage T3, with invasion of perinephric fat or venous … We searched MEDLINE®, Embase®, and the Cochrane Central Register of Controlled Trials (CENTRAL) from

72. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - pulmonary embolism and deep vein thrombosis, which were grouped as thrombotic events; arterial or venous … the convalescent plasma trial were all cause mortality, bleeding events, cardiac arrythmia, acute central … Within 60 days, risk of bleeding events, cardia arrythmia, acute central nervous 27 system … with bacterial infection and a higher proportion of patients with past medical history of deep venous

73. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - information derived in previous levels. 9 Engagement of Stakeholders, Researchers, Funders Central … Fever of unknown origin   Patients with central venous line or other invasive devices who present

74. Making Healthcare Safer IV Rapid Review: Engaging Family Caregivers With Structured Communication for Safe Care Transitions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
    April 01, 2024 - Use of instructional videos to reduce central venous catheter complications in children with intestinal … Improving home caregiver independence with central line care for pediatric cancer patients.

75. Dietary-Supplements Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - electronic databases from inception to September 1, 2011: MEDLINE®, Embase, the Cochrane Library (CENTRAL … Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism

76. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - 35.3% Celecoxib=21.9% p<0.0001 (a) Cardiovascular TE (b) Cerebrovascular TE (c) Peripheral venous … NR Meloxicam NR Thromboembolic events: (A) cardiovascular (B) cerebrovascular (C) peripheral venous

77. Disposition of Comments Report for Pressure Ulcer Risk Assessment and Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
    May 08, 2013 - by Cherry that met inclusion criteria; most of the studies by this author addressed management of venous